Sector
PharmaceuticalsOpen
₹29.14Prev. Close
₹29.14Turnover(Lac.)
₹0.22Day's High
₹29.14Day's Low
₹28.5652 Week's High
₹62.7552 Week's Low
₹21.03Book Value
₹51.16Face Value
₹10Mkt Cap (₹ Cr.)
37.29P/E
0EPS
0Divi. Yield
0Y/e 31 Mar( In .Cr) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
---|---|---|---|---|
Equity Capital | 13.42 | 17.75 | 15.06 | 6.63 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 63.65 | 67.79 | 68.42 | 34.72 |
Net Worth | 77.07 | 85.54 | 83.48 | 41.35 |
Minority Interest |
Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2019 | Mar-2018 |
---|---|---|---|---|
Revenue | 154.37 | 126.83 | 121.69 | 76.04 |
yoy growth (%) | 21.72 | 4.21 | 60.03 | 12.37 |
Raw materials | -103.96 | -88.96 | -87.84 | -52.89 |
As % of sales | 67.34 | 70.14 | 72.17 | 69.55 |
Employee costs | -13.67 | -7.93 | -6.39 | -5.64 |
Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2019 | Mar-2018 |
---|---|---|---|---|
Profit before tax | 10.13 | 8.4 | 8.1 | 4.95 |
Depreciation | -1.31 | -1.22 | -1.12 | -1.19 |
Tax paid | -3.11 | -2.31 | -2.45 | -1.22 |
Working capital | 19.15 | 4.18 | 12.01 | 8.57 |
Other operating items |
Y/e 31 Mar | Mar-2021 | Mar-2020 | Mar-2019 | Mar-2018 |
---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | 21.72 | 4.21 | 60.03 | 12.37 |
Op profit growth | 14.75 | 6.52 | 61.15 | 12.43 |
EBIT growth | 16.24 | 7.86 | 59.96 | 22.36 |
Net profit growth | 15.28 | 7.9 | 51.68 | 31.89 |
Particulars (Rupees in Crores.) | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
---|---|---|---|---|---|
Gross Sales | 92.85 | 146.11 | 219.89 | 354.3 | 154.38 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 92.85 | 146.11 | 219.89 | 354.3 | 154.38 |
Other Operating Income | 0 | 0 | 0 | 0 | 0 |
Other Income | 2.01 | 0.7 | 9.72 | 0.9 | 0.56 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,647.35 | 92.29 | 3,95,254.45 | 2,000.46 | 0.97 | 7,107.14 | 101.44 |
Divis Laboratories Ltd DIVISLAB | 6,493.2 | 78.03 | 1,72,374.06 | 667 | 0.46 | 2,536 | 561.08 |
Cipla Ltd CIPLA | 1,483.15 | 24.33 | 1,19,795.19 | 1,485.4 | 1.08 | 4,254.47 | 397.41 |
Dr Reddys Laboratories Ltd DRREDDY | 1,326.4 | 20.69 | 1,10,689.83 | 1,200.7 | 0.6 | 5,546.3 | 345.79 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,167.95 | 56.27 | 1,07,213.01 | 474 | 1.01 | 2,385 | 224.33 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Managing Director
Rajesh Gupta
Whole Time Director & CFO
Saruchi Gupta
Independent Director
Sukhpal Singh
Independent Director
Chetna
Company Sec. & Compli. Officer
Harshita Aggarwal
Non Executive Director
Rohit Mittal
Independent Director
Harvinder Singh Dhami
Darbara Complex SCO 113 I Flr,
Dist. Shopping Centre B Block,
Punjab - 143001
Tel: 91-0183-5070118/5070119
Website: http://www.anglifesciences.com
Email: cs@anglifesciences.com
E-2/3 Ansa Indl Est,
Saki Vihar Road, Sakinaka Andheri(E),
Mumbai - 400072
Tel: 91-22-40430200/28470
Website: www.bigshareonline.com
Email: investor@bigshareonline.com
Summary
ANG Lifesciences India Limited was originally incorporated as a Private Limited Company with the name ANG Lifesciences India Private Limited on June 14, 2006. On conversion into Public Limited Company...
Read More
Reports by ANG Lifesciences India Ltd
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.